The Effect of E-Health Management on Gestational Diabetes Control
Randomized Controlled Trail of e-Health Management for Women With Prior Gestational Diabetes Mellitus
調査の概要
詳細な説明
Background: Women with previous gestational diabetes mellitus are at increased risk for developing type2 diabetes mellitus or metabolic syndrome in their later life. Infants of mothers with GDM are more susceptible to stillbirth and more serious health concerns. With limited time for visits and the predicament of education, applying web-based intervention has become a convenient tool for health management.
Objectives: The approved project aimed to develop an e-heath management platform(eHMP) for women with high risk of gestational diabetes mellitus (GDM) and to evaluate the longitudinal effects between groups of eHMP intervention. The eHMP integrate GDM health care knowledge, self-awareness of health, self-monitoring of health status (i.e., recording weight and measurement data of metabolic syndrome risk factors and monitoring changes in data trends); participation in discussions or browsing forums; healthy lifestyle guidance and counseling; reminder systems, a token system of earning points in exchange for prizes.
Methods: Pregnant women aged 18-45 years with high risk of metabolic syndrome who have a singleton pregnancy, are eligible to participate in this study. Women who agree to participate in the study will be given a participant information sheet and consent form. Participants will be recruited from the Pregnancy diabetes Clinic, at Chang Gung memorial hospital and introduced to the eHMP using the mobile phone in the clinic. Participants will also be given the URL to access to the program and they can learn the modules at home by using their home PCs, mobile phones, or tablets. They were followed up for three times: 28 weeks' gestation, 36-40 weeks' gestation and 6-12 weeks postpartum. SPSS version 20.0 software was used to compile and analyze the research data, including questionnaires and blood test for metabolic index.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Taipei、台湾、10507
- Chang Gung Memorail Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
Pregnant women (pre-pregnancy body mass index ≧ 24) must meet at least one of the following conditions and agree to be interviewed:
- Age over 34 years old;
- Ever had giant infant delivery (weight ≧ 4.5 kg);
- Previous diagnosed with gestational diabetes ;
- Family history of diabetes.
Exclusion Criteria:
- Pre-existing diabetes (types 1 and 2);
- Unable to write and understand Chinese;
- Subject has cognitive impairment;
- Subject has intellectual disability or mental illness;
- Dependent on medical care (eg, anti-depressants, or any psychiatric medication)
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：防止
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：eHMP experimental group
The experimental group received health management support and counseling,including:
|
Pregnant women who agree to take part will be assigned to a group: experimental group and control group.
The experimental group will received health management support and counseling that were conducted by the researchers through the e-health management platform.
他の名前：
|
|
介入なし：Control group
only received usual care
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change of Triglyceride Level
時間枠：Change from Baseline at 6-12 weeks after delivery
|
Blood sampling was performed in the fasting state.
Normal triglyceride was <150 mg/dl; ≥150mg/dl was abnormal
|
Change from Baseline at 6-12 weeks after delivery
|
|
Change of Fasting Blood Glucose (FBG) Level
時間枠：Change from Baseline at 6-12 weeks after delivery
|
Blood sampling was performed in the fasting state.
Normal FBG was < 100 mg/dl; ≥100mg/dl was abnormal
|
Change from Baseline at 6-12 weeks after delivery
|
|
Change of high-density lipoprotein cholesterol (HDL) level
時間枠：Change from Baseline at 6-12 weeks after delivery
|
Blood sampling was performed in the fasting state.
Normal HDL was ≥50 mg/dl; <50mg/dl was abnormal
|
Change from Baseline at 6-12 weeks after delivery
|
|
Change of Cholesterol level
時間枠：Change from Baseline at 6-12 weeks after delivery
|
Blood sampling was performed in the fasting state.
Normal Cholesterol was < 200 mg/dl; ≥200mg/dl was abnormal
|
Change from Baseline at 6-12 weeks after delivery
|
|
Change of systolic blood pressure
時間枠：Change from Baseline at 6-12 weeks after delivery
|
Normal systolic blood pressure was <130mmHg; ≥130mmHg was abnormal.
Blood pressure was measured at the right arm twice after a 10-min rest in the supine position by using a calibrated sphygmomanometer and averaged.
|
Change from Baseline at 6-12 weeks after delivery
|
|
Change of diastolic blood pressure
時間枠：Change from Baseline at 6-12 weeks after delivery
|
Normal diastolic blood pressure was <85mmHg; ≥85mmHg was abnormal.
Blood pressure was measured at the right arm twice after a 10-min rest in the supine position by using a calibrated sphygmomanometer and averaged.
|
Change from Baseline at 6-12 weeks after delivery
|
|
Change of body weight
時間枠：Change from Baseline at 6-12 weeks after delivery
|
Women's weight following as assessed using calibrated digital scales
|
Change from Baseline at 6-12 weeks after delivery
|
|
Newborn baby weight
時間枠：at birth
|
Newborn baby weight in normal range (>2500g - <4500g) - dichotomous outcome Yes/No assessed using calibrated digital scales.
|
at birth
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change of Pregnancy Physical Activity Assessment
時間枠：Change from Baseline at 6-12 weeks after delivery
|
There are 12 items in this questionnaire, including two dimensions: exercise and inactivity.
Exercise dimension contained four items to assess the type of physical activity, intensity, duration, frequency during pregnancy.
At least 3 days per week, and each time at least 20-30 minutes, counted as regular exercise (dichotomous outcome Yes/No assessed).
Inactivity dimension contained 8 items, dichotomous outcome Yes/No assessed (score 0-8), higher values represent an inactivity lifestyle.
|
Change from Baseline at 6-12 weeks after delivery
|
|
Change of Dietary Behavioral Characteristics Scale
時間枠：Change from Baseline at 6-12 weeks after delivery
|
The instrument is 17-item Likert-type self-report instrument, used a 5-point response format to obtain data regarding the frequency of reported behaviors (never, rarely, sometimes, usually, always).
It including two dimensions and each scale range as: balanced diet (5 items, scale range 5-25) and diet control behavior (12 items, scale range 12-60).
Higher values represent a better maternal dietary patterns during pregnancy.
|
Change from Baseline at 6-12 weeks after delivery
|
|
Change of Health Promotion Scale
時間枠：Change from Baseline at 6-12 weeks after delivery
|
The instrument is 40-item Likert-type self-report instrument, used a 5-point response format to obtain data regarding the frequency of reported behaviors (never, rarely, sometimes, usually, always).
It including six dimensions and each scale range as: social-support (6 items, scale range 6-30), life-appreciation (8 items, scale range 8-40), health-responsibility (8 items, scale range 8-40), stress-management (9 items, scale range 9-45), nutritional behaviors (5 items, scale range 5-25) and exercise behaviors (4 items, scale range 4-20).
The total score was 40 to 200, higher values represent a better health promotion lifestyle.
|
Change from Baseline at 6-12 weeks after delivery
|
協力者と研究者
捜査官
- 主任研究者：Mei-Chen Su, Dr.、Chang Gung Memorial Hospital
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。